Search results for "Hypertensive"

showing 10 items of 250 documents

In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme I…

2020

2019-20 coronavirus outbreakAngiotensinsCoronavirus disease 2019 (COVID-19)Pneumonia ViralAngiotensin-Converting EnzymeACE2InflammationAngiotensin-Converting Enzyme InhibitorsPharmacologyArticleAngiotensin Receptor AntagonistsBetacoronavirusRenin–angiotensin systemmedicineHumansPandemicsAntihypertensive AgentsInflammationAngiotensin Receptor Antagonistsbiologybusiness.industrySARS-CoV-2COVID-19Angiotensin-converting enzymeGeneral MedicineCoronavirusAngiotensin-converting enzyme 2biology.proteinAngiotensin Receptor BlockersAngiotensin-Converting Enzyme COVID-19 coronavirus ACE2medicine.symptombusinessCoronavirus InfectionsCoronavirus InfectionsMayo Clinic proceedings
researchProduct

Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.

2003

Background: The objective of this study was to analyse the relationship of polymorphisms of the angiotensinogen (AGT) gene with the changes in microalbuminuria during 3 years of antihypertensive treatment in a group of young adults with essential hypertension. Methods: Essential hypertensives, less than 50 years old, never previously treated with antihypertensive drugs and in the absence of diabetes mellitus were included. After the initial evaluation, patients were treated using only nonpharmacological measures (n=23), only β-blockers (n=26), only angiotensin-converting enzyme inhibitors (ACEi) (n=57) or a combination of treatments (n=25). The office blood pressure, biochemical profile and…

AdultBlood GlucoseMalemedicine.medical_specialtyTime FactorsGenotypeAdrenergic beta-AntagonistsAngiotensinogenAngiotensin-Converting Enzyme InhibitorsBlood PressureEssential hypertensionExcretionDiabetes mellitusInternal medicineInternal MedicinemedicineAlbuminuriaHumansAntihypertensive AgentsProteinuriaPolymorphism Geneticbusiness.industrymedicine.diseaseEndocrinologyBlood pressureTreatment OutcomeACE inhibitorHypertensionMicroalbuminuriaFemaleGene polymorphismmedicine.symptombusinessmedicine.drugFollow-Up StudiesJournal of human hypertension
researchProduct

Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension

2005

The objective was to assess the temporal impact of factors related to the development of microalbuminuria during the follow-up of young adult normoalbuminurics with high-normal blood pressure or at stage 1 of essential hypertension. Prospective follow-up was conducted on 245 normoalbuminuric hypertensive subjects (mean age 40.9 years; 134 men; blood pressure 139.7/88.6 mm Hg; body mass index 28.5 kg/m 2 ) never treated previously with antihypertensive drugs, with yearly urinary albumin excretion measurements, until the development of microalbuminuria. After enrollment, patients were placed on usual care including nonpharmacological treatment or with an antihypertensive drug regime to achie…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.drug_classBlood PressureEssential hypertensionPrehypertensionRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaHumansProspective StudiesAntihypertensive drugAntihypertensive AgentsProportional Hazards ModelsProteinuriabusiness.industryFastingmedicine.diseaseEndocrinologyBlood pressureHypertensionMultivariate AnalysisDisease ProgressionAlbuminuriaCardiologyFemaleMicroalbuminuriamedicine.symptombusinessBody mass indexFollow-Up StudiesHypertension
researchProduct

Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries

2015

To assess the diagnostic value of cardiac MRI (CMR) in patients with acute chest pain, elevated cardiac enzymes and a negative coronary angiogram.This study included a total of 125 patients treated in the chest pain unit during a 39-month period. Each included patient underwent MRI within a median of 3 days after cardiac catheterization. The MRI protocol comprised cine, oedema-sensitive and late gadolinium-enhancement imaging. The standard of reference was a consensus diagnosis based on clinical follow-up and the synopsis of all clinical, laboratory and imaging data.MRI revealed a multitude of diagnoses, including ischaemic cardiomyopathy (CM), dilated CM, myocarditis, Takotsubo CM, hyperte…

AdultGadolinium DTPAMalemedicine.medical_specialtyCardiac CatheterizationChest PainMyocarditismedicine.medical_treatmentContrast MediaMagnetic Resonance Imaging CineChest painCoronary AngiographyRisk AssessmentPredictive Value of TestsRisk FactorsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingMedical diagnosisCardiac catheterizationAgedAged 80 and overFull Paperbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseHypertensive heart diseaseCoronary arteriesmedicine.anatomical_structureCardiac amyloidosisCardiovascular DiseasesPredictive value of testscardiovascular systemCardiologyFemaleRadiologymedicine.symptombusinessBiomarkers
researchProduct

Cardiac involvement in Friedreich's ataxia: our experience.

2009

AdultMaleAdolescentIncidenceFriedreich's ataxiaMiddle AgedAntioxidantsSampling StudiesFriedreich AtaxiaPrevalenceHumansFemaleHypertrophy Left VentricularSicilyAntihypertensive AgentsFollow-Up StudiesRetrospective Studies
researchProduct

Physician attitudes to blood pressure control

2011

OBJECTIVES: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey aimed to qualify the key challenges that physicians face when trying to get patients to blood pressure (BP) goal. METHODS: The SHARE survey was open to physicians involved in the treatment of patients with hypertension, was anonymous, and was designed to take 15 min to complete. The survey included 45 questions covering physicians' demographic information, views on the BP targets recommended by the European Society of Hypertension-European Society of Cardiology guidelines, opinions on acceptable levels of BP control, and perceptions about the challenges associated with getting patients to BP …

AdultMaleBlood pressure controlHealth Knowledge Attitudes Practicemedicine.medical_specialtyBiomedical ResearchAttitude of Health PersonnelPhysiologyElevated bpMEDLINEBlood PressureRisk AssessmentPhysiciansSurveys and QuestionnairesInternal MedicineHumansMedicinePractice Patterns Physicians'Antihypertensive Agentsbusiness.industryGuideline adherenceGuidelineAwarenessMiddle AgedHealth SurveysEuropeBlood pressureCardiovascular DiseasesPhysician surveyFamily medicineHypertensionFemaleGuideline AdherenceCardiology and Cardiovascular MedicinebusinessRisk assessmentJournal of Hypertension
researchProduct

Inadequate Cytoplasmic Antioxidant Enzymes Response Contributes to the Oxidative Stress in Human Hypertension

2006

Untreated hypertensive patients show increased oxidative stress and decreased antioxidant enzyme activity in mononuclear cells. Therefore, the objective of this study was to determine whether or not the low antioxidant enzyme activity observed in mononuclear cells of hypertensive subjects is in part dependent on a defective activity of antioxidant mechanisms. Activity and mRNA level of antioxidant enzymes, CuZn- and Mn-superoxide dismutases, catalase, glutathione peroxidase type 1, and glutathione reductase were simultaneously measured in mononuclear cells of controls (n = 38) and hypertensive subjects (n = 35), in the absence of and during antihypertensive treatment. An increase in oxidati…

AdultMaleCytoplasmmedicine.medical_specialtyAntioxidantmedicine.medical_treatmentGlutathione reductasemedicine.disease_causeAntioxidantsSuperoxide dismutasechemistry.chemical_compoundGlutathione Peroxidase GPX1Internal medicineInternal MedicinemedicineHumansRNA MessengerAntihypertensive Agentschemistry.chemical_classificationGlutathione PeroxidasebiologySuperoxide Dismutasebusiness.industryGlutathione peroxidaseNADPH OxidasesGlutathioneMiddle AgedCatalaseOxidative StressGlutathione ReductaseEndocrinologychemistryCase-Control StudiesHypertensionbiology.proteinFemaleDismutaseOxidoreductasesbusinessOxidative stressPeroxidaseAmerican Journal of Hypertension
researchProduct

Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: A case report

2002

Reversible posterior leukoencephalopathy syndrome (RPLS) is an uncommon entity related to multiple and different pathologies, the most common being hypertensive crisis. It is believed to be secondary to the breakdown on the blood-brain barrier. At the beginning, it is undistinguishable from other leukoencephalopathies. However, the disappearance of brain lesions after removal of the potential cause, establish the differential diagnosis with other leukoencephalopathies. We present the case of an HIV-infected patient with a RPLS related to a hypertensive crisis short after the initiation of indinavir-containing highly active antiretroviral therapy. Once blood pressure was controlled and indin…

AdultMalePathologymedicine.medical_specialtyHypertensive encephalopathymedicine.medical_treatmentHIV InfectionsIndinavirIndinavirAntiretroviral Therapy Highly ActiveHypertensive EncephalopathyInternal MedicinemedicineHumansChemotherapymedicine.diagnostic_testbusiness.industryProgressive multifocal leukoencephalopathyvirus diseasesMagnetic resonance imagingHIV Protease Inhibitorsmedicine.diseaseMagnetic Resonance ImagingHyperintensityNelfinavirDifferential diagnosisbusinessmedicine.drugAmerican Journal of Hypertension
researchProduct

Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk:An International …

2017

Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99. mm. Hg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treat…

AdultMaleRiskmedicine.medical_specialtyPediatricsEvidence-based practiceHeart Diseasesmedicine.drug_classMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineHypertension/complicationsEpidemiologymedicineHumans030212 general & internal medicineRisk factorAntihypertensive drugAntihypertensive AgentsDisease burdenAntihypertensive Agents/therapeutic usebusiness.industryPublic healthHeart Diseases/etiologyGeneral MedicineHypertensionFemaleCardiology and Cardiovascular MedicinebusinessPsychosocial
researchProduct

World Hypertension Day 2021 in Italy: Results of a Nationwide Survey

2022

Introduction: Hypertension is the biggest contributor to the global burden of cardiovascular diseases and related death, but the rates of hypertension awareness, treatment, and control remain largely perfectible. Methods: During the XVII World Hypertension Day (May 17th, 2021), a nationwide cross-sectional opportunistic study endorsed by the Italian Society of Hypertension was conducted on volunteer adults ≥ 18 years to raise awareness of high blood pressure (BP). A questionnaire on major demographic/clinical features (sex, age, employment, education, BP status awareness, hypertension family/personal history, antihypertensive medications use) and BP measurement habits (≥1 BP measurement in …

AdultMaleSettore MED/14 - Nefrologiaawareness; blood pressure; hypertension; surveySettore MED/09 - Medicina InternaSARS-CoV-2AwareneCOVID-19Middle AgedAwarenessCross-Sectional StudiesRisk FactorsSurveys and QuestionnairesAwareness Blood pressure Hypertension SurveyHypertensionInternal MedicineBlood pressureHumansFemaleAwareness; Blood pressure; Hypertension; Survey; Adult; Aged; Antihypertensive Agents; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; COVID-19; HypertensionCardiology and Cardiovascular MedicineSurveyAntihypertensive AgentsAged
researchProduct